Soluble Forms of Toll-Like Receptor (TLR)2 Capable of Modulating TLR2 Signaling Are Present in Human Plasma and Breast Milk

Journal of Immunology

Volumn 171, Issue 12, 2003, Pages 6680-6689

  LeBouder, Emmanuel ^a   Rey Nores, Julia E ^a   Rushmere, Neil K ^a   Grigorov, Martin ^b   Lawn, Stephen D ^c   Affolter, Michael ^b   Griffin, George E ^c   Ferrara, Pascual ^d   Schiffrin, Eduardo J ^b   Morgan, B Paul ^a   Labéta, Mario O ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 BIS(PALMITOYLOXY) 2 PROPYL 1 PALMITOYLCYSTEINE; 2,3-BIS(PALMITOYLOXY)-2-PROPYL-1-PALMITOYLCYSTEINE; CD14 ANTIGEN; CELL SURFACE RECEPTOR; COMPLEMENTARY DNA; CYSTEINE; DRUG DERIVATIVE; HYBRID PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; ISOPROTEIN; LIPOPEPTIDE; LIPOPROTEIN; MEMBRANE PROTEIN; MONENSIN; PEPTIDE; PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BACTERIAL INFECTION; BIOSYNTHESIS; BLOOD; BREAST MILK; CELL ACTIVATION; CELL CULTURE; CELL LINE; CELL MEMBRANE; CHEMISTRY; CHO CELL; COMPUTATIONAL MOLECULAR DOCKING; COMPUTER MODEL; CONTROLLED STUDY; DEATH; DOWN REGULATION; DRUG EFFECT; FEMALE; GENETICS; HUMAN; IMMUNE RESPONSE; IMMUNOLOGY; INFECTION; INTRACELLULAR FLUID; ISOLATION AND PURIFICATION; MACROPHAGE ACTIVATION; METABOLISM; MOLECULAR BIOLOGY; MOLECULAR GENETICS; MOLECULAR MODEL; MONOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PLASMA; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PROCESSING; PROTEIN TRANSPORT; REGULATORY MECHANISM; SEPTIC SHOCK; SERODIAGNOSIS; SIGNAL TRANSDUCTION; SOLUBILITY; TUBERCULOSIS;

EID: 10744233851     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.12.6680     Document Type: Article

References (45)

1. Glauser, M. P., D. Heumann, J. D. Baumgartner, and J. Cohen. 1994. Pathogenesis and potential strategies for prevention and treatment of septic shock: an update. Clin. Infect. Dis. 18:S205.
2. Bone, R. C., R. A. Balk, F. B. Cerra, R. P. Dellinger, A. M. Fein, W. A. Knaus, R. M. H. Schein, and W. J. Sibbald. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101:1644.
3. Ulevitch, R. J. 2001. New therapeutic targets revealed through investigations of innate immunity. Crit. Care Med. 29:S8.
4. Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nat. Rev. 1:135.
5. Underhill, D. M., and A. Ozinsky. 2002. Toll-like receptors: key mediators of microbe detection. Curr. Opin. Immunol. 14:103.
6. Lien, E., T. J. Sellati, A. Yoshimura, T. H. Flo, G. Rawadi, R. W. Finberg, J. D. Carroll, T. Espevik, R. R. Ingalls, J. D. Radolf, and D. T. Golenbock. 1999. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem. 274:33419.
7. Kirschning, C. J., and R. R. Schumann. 2002. TLR2: cellular sensor for microbial and endogenous molecular patterns. Curr. Top. Microbiol. Immunol. 270:121.
8. Bieback, K., E. Lien, I. M. Klagge, E. Avota, J. Schneider-Schaulies, W. P. Duprex, H. Wagner, C. J. Kirschning, V. ter Meulen, and S. Schneider-Schaulies. 2002. Hemagglutining protein of wild-type measels virus activates Toll-like receptor 2 signaling. J. Virol. 76:8729.
9. Da Silva Correia, J., K. Soldau, U. Christen, P. S. Tobias, and R. J. Ulevitch. 2001. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex: transfer from CD14 to TLR4 and MD-2. J. Biol. Chem. 276:21129.
10. Brightbill, H. D., D. H. Libraty, S. R. Krutzik, R.-B. Yang, J. T. Belisle, J. R. Bleharski, M. Maitland, M. V. Norgard, S. E. Plevy, S. T. Smale, et al. 1999. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science 285:732.
11. Yoshimura, A., E. E. Lien, R. R. Ingalls, E. Tuomanen, R. Diarzki, and D. Golenbock. 1999. Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. ImmunoL 163:1.
12. Haziot, A., E. Ferrero, F. Köntgen, N. Hijiya, S. Yamamoto, J. Silver, C. L. Stewart, and, S. Goyert. 1996. Resistance to endotoxin shock and reduced dissemination of bacteria in CD14-deficient mice. Immunity 4:407.
13. Bazil, V., V. Horejsi, M. Baudys, H. Kristofova, J. L. Strominger, W. Kostka, and I. Hilgert. 1986. Biochemical characterization of a soluble form of the 54-kDa monocyte surface antigen. Eur. J. Immunol. 16:1583.
14. Durieux, J. J., N. Vita, O. Popescu, F. Guette, J. Calzada-Wack, R. Munker, R. E. Schmidt, J. Lupker, P. Ferrara, H. W. L. Ziegler-Heitbrock, and M. O. Labéta. 1994. The two soluble forms of the lipopolysaccharide receptor, CD14: characterization and release by normal human monocytes. Eur. J. Immunol. 24:2006.
15. Frey, E. A., D. S. Miller, T. G. Jahr, A. Sundan, V. Bazil, T. Espevik, B. B. Finlay, and S. D. Wright. 1992. Soluble CD14 participates in the response of cells to lipopolysaccharide. J. Exp. Med. 176:1665.
16. Labéta, M. O., K. Vidal, J. E. Rey-Nores, M. Arias, N. Vita, B. P. Morgan, J. C. Gullemot, D. Loyaux, P. Ferrara, D. Schmid, et al. 2000. Innate recognition of bacteria in human milk is mediated by a milk-derived highly expressed pattern recognition receptor, soluble CD14. J. Exp. Med. 191:1807.
17. Filipp, D., K. Alizadeh-Khiavi, C. Richardson, A. Palma, N. Paredes, O. Takeuchi, S. Akira, and M. Julius. 2001. Soluble CD14 enriched in colostrum and milk induces B cell growth and differentiation Proc. Natl. Acad. Sci. USA 98:603.
18. Kaisho, T., and S. Akira. 2002. Toll-like receptors as adjuvant receptors. Biochim. Biophys. Acta 1589:1.
19. Heany, M., and D. W. Golde. 1998. Soluble receptors in human disease, J. Leukocyte Biol. 64:135.
20. Mantovani, A., M. Locati, A. Vecchi, S. Sozzani, and P. Allavena. 2001. Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. Trends Immunol. 22:328.
21. + patients with tuberculosis in Africa: prolonged elevation during anti-tuberculosis treatment. Clin. Exp. Immunol. 120:483.
22. Labéta, M. O., J.-J. Durieux, N. Fernandez, R. Herrmann, and P. Ferrara. 1993. Release from a human monocyte-like cell line of two different soluble forms of the lipopolysaccharide receptor, CD14. Eur. J. Immunol. 9:2144.
23. Coligan J. E. 1995. Extraction and partitioning of total proteins from cells and membranes with Triton X-114. In Current Protocols in Protein Science, Vol. 2. J. E. Coligan, B. M. Dunn, H. L. Ploegh, D. N. Speicher, and P. T. Wingfield, eds. J. Wiley & Sons, New York, Suppl. 2, p. 12.5.3.
24. Rey-Nores, J. E., A. Bensussan, N. Vita, F. Stelter, M. A. Arias, M. Jones, S. Lefort, L. K. Borysiewicz, P. Ferrara, and M. O. Labéta 1999. Soluble CD14 acts as a negative regulator of human T cell activation and function. Eur. J. Immunol. 29:265.
25. Hinchliffe, S. J., N. K. Rushmere, S. M. Hanna, and B. P. Morgan. 1998. Molecular cloning and functional characterization of the pig analogue of CD59: relevance to xenotransplantation J. Immunol. 160:3924.
26. Harris, C. L., D. M. Lublin, and B. P. Morgan. 2002. Efficient generation of monoclonal antibodies for specific protein domains using recombinant immunoglobulin fusion proteins: pitfalls and solutions. J. Immunol. Methods 268:245.
27. Kelley, L. A., R. Maccallum, and M. J. E. Sternberg. 1999. Recognition of remote protein homologies using three-dimensional information to generate a position specific scoring matrix in the program 3D-PSSM. RECOMB 99: Proceedings of the Third Annual Conference on Computational Molecular Biology, April 11-14. S. Istrail, P. Pevzner, and M. Waterman eds. The Association for Computing Machinery, New York, p. 218.
28. Kajava, A. V. 1998. Structural diversity of leucin-rich repeat proteins. J. Mol. Biol. 277:519.
29. Evdokimov, A. G., D. E. Anderson, K. M. Routzahn, and D. S. Waugh. 2001. Unusual molecular architecture of the Yersinia pestis cytotoxin YopM: a leucine-rich repeat protein with the shortest repeating unit. J. Mol. Biol. 312:807.
30. Katchalski-Katzir, E., I. Shariv, M. Eisenstein, A. A. Friesem, C. Aflalo, and I. A. Vakser, 1992. Molecular surface recognition: determination of geometric fit between proteins and their ligands by correlation techniques. Proc. Natl. Acad. Sci. USA 89:2195.
31. Jorgensen, P., L. William, and J. Tirado-Rives. 1988. The OPLS (optimized potentials for liquid simulations) potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin. J. Am. Chem. Soc. 110:1657.
32. Flo, T. H., O. Halaas, S. Torp, L. Ryan, E. Lien, B. Dybdahl, A. Sundan, and T. Espevik. 2001. Differential expression of Toll-like receptor 2 in human cells. J. Leukocyte Biol. 69:474.
33. Yang, R.-B., M. R. Mark, A. L. Gurney, and P. Godowski. 1999. Signaling events induced by lipopolysaccharide-activated Toll-like receptor 2. J. Immunol. 163:639.
34. Mollenhauer, H. H., D. J. Morre, and L. D. Rowe. 1990. Alteration of intracellular traffic by monensin: mechanism, specificity and relationship to toxicity. Biochim. Biophys. Acta 1031:225.
35. Underhill, D. M., A. Ozinsky, A. M. Hajjar, A. Stevens, C. B. Wilson, M. Bassetti, and A. Aderem. 1999. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401:811.
36. Fusunyan, R. D., N. N. Nanthakumar, M. E. Baldeon, and W. A. Walker. 2001. Evidence for an innate immune response in the immature human intestine: Toll-like receptors on fetal enterocytes. Pediatr. Res. 49:589.
37. Nanthakumar, N. N., R. D. Fusunyan, I. Sanderson, and W. A Walker. 2000. Inflammation in the developing human intestine: a possible pathophysiological contribution to necrotizing enterocolitis. Proc. Natl. Acad. Sci USA 97:6043.
38. Lin, Y., H. Lee, A. H. Berg, M. P. Lisanti, L. Shapiro, and P. E. Scherer. 2000. The lipopolysaccharide-activated Toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes. J. Biol. Chem. 275:24255.
39. Kurt-Jones, E. A., L. Mandell, C. Whitney, A. Padgett, K. Gosselin, P. E. Newburger, and W. Finberg. 2002. Role of Toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils. Blood 100:1860.
40. Nomura, F., S. Akashi, Y. Sakao, S. Sato, T. Kawai, M. Matsumoto, K. Nakanishi, M. Kimoto, K. Miyake, K. Takeda, and S. Akira. 2000. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface Toll-like receptor 4 expression. J. Immunol. 164:3476.
41. Ozinsky, A., D. M. Underhill, J. D. Fontenot, A. M. Adjjar, K. D. Smith, C. B. Wilson, L. Shroeder, and A. Aderem. 2000. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc. Natl. Acad. Sci. USA 97:13766.
42. Takeuchi, O., T. Kawai, P. F. Muhlradt, M. Morr., J. D. Radolf, A. Zychlinsky, K. Takeda, and S. Akira. 2001. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 13:933.
43. Aliprantis, A. O., R.-B. Yang, M. R. Mark, S. Suggett, B. Devaux, J. D. Radolf, G. R. Klimpel, P. Godowski, and A. Zychlinsky. 1999. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science 285:736.
44. Iwami, K., T. Matsuguchi, A. Masuda, T. Kikuchi, T. Musikacharoen, and Y. Yoshikai. 2001. Cutting edge: naturally occurring soluble form of mouse Toll-like receptor 4 inhibits lipopolysaccharide signaling. J. Immunol. 165:6682.
45. Iwaki, D., H. Mitsuzawa, S. Murakami, H. Sano, M. Konishi, T. Akino, and Y. Kuroki. 2002. The extracellular Toll-like receptor 2 domain directly binds peptidoglycan derived from Staphylococcus aureus. J. Biol. Chem. 277:24315.